MUMBAI Feb 4 Indian drugmaker Glenmark
Pharmaceuticals said on Monday it has discovered a new
molecule that can be used to treat diseases such as rheumatoid
arthritis and inflammatory bowel disease.
The new molecule, named GBR 830, is an anti-OX40 monoclonal
antibody, Glenmark said in a statement, adding that OX40 is
responsible for some autoimmune diseases.
The company said it has initiated studies for an
investigational new drug (IND) application to be filed with the
U.S. Food and Drug Administration.
(Reporting by Kaustubh Kulkarni in Mumbai; Editing by Jijo